The anti-malarial drug atovaquone potentiates platinum-mediated cancer cell death by increasing oxidative stress
Platinum chemotherapies are highly effective cytotoxic agents but often induce resistance when used as monotherapies. Combinatorial strategies limit this risk and provide effective treatment options for many cancers. Here, we repurpose atovaquone (ATQ), a well-tolerated & FDA-approved anti-malar...
Main Authors: | Coates, JTT, Rodriguez-Berriguete, G, Puliyadi, R, Ashton, T, Prevo, R, Wing, A, Granata, G, Pirovano, G, McKenna, GW, Higgins, GS |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2020
|
Subjects: |
Similar Items
-
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
by: Ashton, T, et al.
Published: (2016) -
Investigating the role of the anti-malarial drug Atovaquone in anti-cancer therapy
by: Watson, D, et al.
Published: (2019) -
CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner
by: Prevo, R, et al.
Published: (2018) -
Nucleoporin 54 contributes to Homologous recombination repair and post-replicative DNA integrity
by: Rodriguez-Berriguete, G, et al.
Published: (2018) -
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models
by: Gonzalo Rodriguez-Berriguete, et al.
Published: (2024-01-01)